GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Ortho Clinical Diagnostics Holdings PLC (NAS:OCDX) » Definitions » Piotroski F-Score

Ortho Clinical Diagnostics Holdings (Ortho Clinical Diagnostics Holdings) Piotroski F-Score : N/A (As of Apr. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ortho Clinical Diagnostics Holdings Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Ortho Clinical Diagnostics Holdings has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Ortho Clinical Diagnostics Holdings's Piotroski F-Score or its related term are showing as below:

During the past 5 years, the highest Piotroski F-Score of Ortho Clinical Diagnostics Holdings was 9999. The lowest was 7. And the median was 7.


Ortho Clinical Diagnostics Holdings Piotroski F-Score Historical Data

The historical data trend for Ortho Clinical Diagnostics Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ortho Clinical Diagnostics Holdings Piotroski F-Score Chart

Ortho Clinical Diagnostics Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21
Piotroski F-Score
N/A N/A N/A N/A 7.00

Ortho Clinical Diagnostics Holdings Quarterly Data
Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A 7.00 7.00 N/A

Competitive Comparison of Ortho Clinical Diagnostics Holdings's Piotroski F-Score

For the Diagnostics & Research subindustry, Ortho Clinical Diagnostics Holdings's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ortho Clinical Diagnostics Holdings's Piotroski F-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Ortho Clinical Diagnostics Holdings's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Ortho Clinical Diagnostics Holdings's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar22) TTM:Last Year (Mar21) TTM:
Net Income was -20 + 14.7 + -9.9 + 14.8 = $-0 Mil.
Cash Flow from Operations was 132.7 + 65.4 + 98.4 + -4 = $293 Mil.
Revenue was 492.5 + 522.5 + 521 + 500.1 = $2,036 Mil.
Gross Profit was 244.4 + 270.1 + 262.9 + 250.6 = $1,028 Mil.
Average Total Assets from the begining of this year (Mar21)
to the end of this year (Mar22) was
(3392.5 + 3304.2 + 3309.9 + 3363.8 + 3316.4) / 5 = $3337.36 Mil.
Total Assets at the begining of this year (Mar21) was $3,393 Mil.
Long-Term Debt & Capital Lease Obligation was $2,177 Mil.
Total Current Assets was $990 Mil.
Total Current Liabilities was $523 Mil.
Net Income was -41.3 + -28.5 + -40.9 + -39.1 = $-150 Mil.

Revenue was 390.5 + 451.1 + 516.6 + 506.8 = $1,865 Mil.
Gross Profit was 187.6 + 217 + 258.6 + 258.6 = $922 Mil.
Average Total Assets from the begining of last year (Mar20)
to the end of last year (Mar21) was
(0 + 0 + 3334.6 + 3401.5 + 3392.5) / 5 = $3376.2 Mil.
Total Assets at the begining of last year (Mar20) was $0 Mil.
Long-Term Debt & Capital Lease Obligation was $2,240 Mil.
Total Current Assets was $920 Mil.
Total Current Liabilities was $565 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Ortho Clinical Diagnostics Holdings's current Net Income (TTM) was -0. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Ortho Clinical Diagnostics Holdings's current Cash Flow from Operations (TTM) was 293. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar21)
=-0.4/3392.5
=-0.00011791

ROA (Last Year)=Net Income/Total Assets (Mar20)
=-149.8/0
=

Ortho Clinical Diagnostics Holdings's return on assets of this year was -0.00011791. Ortho Clinical Diagnostics Holdings's return on assets of last year was . ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Ortho Clinical Diagnostics Holdings's current Net Income (TTM) was -0. Ortho Clinical Diagnostics Holdings's current Cash Flow from Operations (TTM) was 293. ==> 293 > -0 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar21 to Mar22
=2177.1/3337.36
=0.65234197

Gearing (Last Year: Mar21)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar20 to Mar21
=2240.3/3376.2
=0.66355666

Ortho Clinical Diagnostics Holdings's gearing of this year was 0.65234197. Ortho Clinical Diagnostics Holdings's gearing of last year was 0.66355666. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar22)=Total Current Assets/Total Current Liabilities
=989.6/522.7
=1.8932466

Current Ratio (Last Year: Mar21)=Total Current Assets/Total Current Liabilities
=919.8/564.9
=1.62825279

Ortho Clinical Diagnostics Holdings's current ratio of this year was 1.8932466. Ortho Clinical Diagnostics Holdings's current ratio of last year was 1.62825279. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Ortho Clinical Diagnostics Holdings's number of shares in issue this year was 242. Ortho Clinical Diagnostics Holdings's number of shares in issue last year was 0. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1028/2036.1
=0.50488679

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=921.8/1865
=0.49426273

Ortho Clinical Diagnostics Holdings's gross margin of this year was 0.50488679. Ortho Clinical Diagnostics Holdings's gross margin of last year was 0.49426273. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar21)
=2036.1/3392.5
=0.60017686

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar20)
=1865/0
=

Ortho Clinical Diagnostics Holdings's asset turnover of this year was 0.60017686. Ortho Clinical Diagnostics Holdings's asset turnover of last year was . ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+1+1+1+1+0+1+1
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Ortho Clinical Diagnostics Holdings has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Ortho Clinical Diagnostics Holdings  (NAS:OCDX) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Ortho Clinical Diagnostics Holdings Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Ortho Clinical Diagnostics Holdings's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Ortho Clinical Diagnostics Holdings (Ortho Clinical Diagnostics Holdings) Business Description

Traded in Other Exchanges
N/A
Address
1001 Route 202, Raritan, NJ, USA, 08869
Ortho Clinical Diagnostics Holdings PLC offers in vitro diagnostics solutions and services. It provides diagnostic testing solutions to the clinical laboratory and transfusion medicine communities. The company operates through three geographic segments such as Americas, EMEA, Greater China, and Other. Americas segment generates most of the revenue for the firm.
Executives
Robert Clifton Yates director C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS 1001 ROUTE 202 RARITAN NJ 08869
Chockalingam Palaniappan officer: Chief Innovation Officer C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS 1001 ROUTE 202 RARITAN NJ 08869
Christopher M Smith director, officer: Chairman and CEO 125 CONSTITUTION DRIVE, MENLO PARK CA 94025
Michael S. Iskra officer: Executive Vice President C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS, 1001 ROUTE 202, RARITAN NJ 08869
Joseph M Busky officer: Chief Financial Officer 1717 DEERFIELD ROAD, DEERFIELD IL 60015
Michael A. Schlesinger officer: EVP, GC and Secretary C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS 1001 ROUTE 202 RARITAN NJ 08869
Carlyle Partners Vi Cayman Holdings, L.p. 10 percent owner C/O WALKERS CORPORATE LIMITED, CAYMAN CORPORATE CENTRE, 27 HOSPITAL RD., GEORGE TOWN, GRAND CAYMAN E9 KY1-9008
Tc Group Vi Cayman, L.l.c. 10 percent owner C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tc Group Vi Cayman, L.p. 10 percent owner C/O WALKERS CORPORATE LIMITED, CAYMAN CORPORATE CENTRE, 27 HOSPITAL RD., GEORGE TOWN, GRAND CAYMAN E9 KY1-9008
Cg Subsidiary Holdings L.l.c. 10 percent owner C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tc Group Cayman Investment Holdings Sub L.p. 10 percent owner C/O WALKER CORPORATE SERVICES LIMITED, 190 ELGIN AVENUE, GEORGE TOWN, GRAND CAYMAN E9 KY1-9001
Carlyle Holdings Ii L.l.c. 10 percent owner C/O THE CARLYLE GROUP L.P., 1001 PENNSYLVANIA AVENUE, NW, WASHINGTON DC 20004-2505
Carlyle Holdings Ii Gp L.l.c. 10 percent owner C/O THE CARLYLE GROUP L.P., 1001 PENNSYLVANIA AVENUE, NW, WASHINGTON DC 20004-2505
Carlyle Group Inc. 10 percent owner C/O THE CARLYLE GROUP, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tc Group Cayman Investment Holdings, L.p. 10 percent owner C/O WALKERS CORPORATE SERVICES LIMITED, 190 ELGIN AVENUE, GEORGE TOWN, GRAND CAYMAN E9 KY1-9001

Ortho Clinical Diagnostics Holdings (Ortho Clinical Diagnostics Holdings) Headlines

From GuruFocus